SCHEMBL17996090

SCHEMBL17996090

CC1(C)c2ccc(Br)cc2-c2cc3c4ccccc4n(-c4ccccc4)c3cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ PDE4B Q07343 1/20 0.38
▸ TSPO P30536 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ RXFP1 Q9HBX9 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPK8 P45983 1/20 0.32
▸ ACHE P22303 1/20 0.31
▸ PGR P06401 2/20 0.31
▸ CCNE2 O96020 1/20 0.31
▸ CDK4 P11802 1/20 0.31
▸ CCND1 P24385 1/20 0.31
▸ CCNE1 P24864 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12925461 0.93 L3MBTL1 (0.45) L3MBTL1KDM4EATMPDE4BTSPO
SCHEMBL802130 0.89 KDM4E (0.56) L3MBTL1KDM4EATMMEN1MAPT
SCHEMBL14822438 0.88 KDM4E (0.55) L3MBTL1KDM4EATMMEN1MAPT
SCHEMBL801946 0.88 KDM4E (0.55) L3MBTL1KDM4EATMMEN1MAPT
SCHEMBL18201371 0.88 L3MBTL1 (0.43) L3MBTL1KDM4EATMPDE4BMEN1
SCHEMBL18351606 0.88 L3MBTL1 (0.38) L3MBTL1KDM4EATMPDE4BTSPO
SCHEMBL1755107 0.88 KDM4E (0.38) L3MBTL1KDM4EATMTSPOMAPT
SCHEMBL782285 0.88 PGR (0.35) L3MBTL1KDM4EATMPDE4BRXFP1
SCHEMBL30866249 0.88 PGR (0.35) L3MBTL1KDM4EATMPDE4BRXFP1
SCHEMBL2609904 0.88 L3MBTL1 (0.45) L3MBTL1KDM4EATMPDE4BTSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160233442-A1 IRIDIUM COMPLEXES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION 2016-08-11 — — US disclosed
US-20160233442-A1 IRIDIUM COMPLEXES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION 2016-08-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160233442-A1 IRIDIUM COMPLEXES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME H1-0, H1-4, H1-3 L3MBTL1 199/4885KDM4E 1458/4885ATM 4434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback